失脂血症与前部循环单次皮质下心脏病发作患者的渐进性心脏病发作有关
Shumeng Li1, Liangbin Dong2, Qin Huang1
1Department of Neurology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330000, China.
概括
三甘油 (TG) 和低密度脂蛋白胆固醇 (LDL-c) 预测前循环单次皮下心脏病发作 (ACSSI) 患者的渐进性心脏病发作 (PI). 与其他脂质标志物相比,TG是ACSSI中PI的优越预测因素.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 生物化学 生物化学
背景情况:
- 前进性心脏病发作 (PI) 的预测因素可能在前循环单次皮下心脏病发作 (ACSSI) 和关单次心脏病发作 (PSI) 之间有所不同.
- 了解这些预测因素对于管理中风患者至关重要.
研究的目的:
- 评估在ACSSI或PSI患者中各种脂质标记物和PI之间的关联.
- 为了确定优越的脂质标记物来预测特定中风亚型中的PI.
主要方法:
- 对2020年1月至2022年10月期间入院的629名患者 (ACSSI和PSI) 的回顾性分析.
- 在入院24小时内收集了七种脂质标记物 (总胆固醇,甘油三,HDL-c,LDL-c,ApoA-I,ApoB,脂蛋白).
- 使用单变量分析,多变量逻辑回归和接收器操作特征曲线.
主要成果:
- 18.9%的患者经历了PI.
- 在PI患者中观察到总胆固醇,甘油三,LDL-c和ApoB的较高水平.
- 在ACSSI患者中,甘油三和LDL-c与PI有关,甘油三是优异的预测因素.
结论:
- 甘油三和LDL-c与ACSSI患者的进展性心脏病发作有关.
- 在ACSSI中,甘油三是一种比其他测试的脂质标记物更有效的PI预测剂.
相关概念视频
Peripheral Artery Disease I: Introduction
9
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
11
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
11
Atherosclerosis I: Introduction
9
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
9
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
20
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12


